Nanophase Reports Fourth Quarter and Year End 2023 Results, New Financing Package
ROMEOVILLE, Ill., March 20, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced financial results for the fourth quarter and fiscal year ended December 31, 2023.
- Revenue for the fourth quarter was $8 million, vs. $8.3 million for the same period in 2022.
- Additional capital was secured with a $6 million financing package announced in March 2024.
- Net loss for the quarter was $2.1 million in 2023, compared to $2.0 million for Q4 of 2022.
- In 2023, Nanophase and Solésence Beauty Science were named in Fast Company’s World’s Most Innovative Companies for 2023, positioning us as No.